In an op-ed, TheraPsil President & CEO Spencer Hawkswell argues for the inclusion of psilocybin-assisted therapy in Canada’s healthcare system, pointing to the transformative impact it can have, especially in comparison to existing treatments like opioid replacement therapy. Hawkswell calls for urgent action from health ministers to grant medical exemptions and emphasizes the moral imperative of exploring innovative treatments.

Discover the full depth of the issue and the proposed compassionate solution at the Georgia Straight here.

Share this post